Nothing Special   »   [go: up one dir, main page]

DK315387D0 - Androst-4-en-3,17-dioner og fremgangsmaade til fremstilling deraf - Google Patents

Androst-4-en-3,17-dioner og fremgangsmaade til fremstilling deraf

Info

Publication number
DK315387D0
DK315387D0 DK315387A DK315387A DK315387D0 DK 315387 D0 DK315387 D0 DK 315387D0 DK 315387 A DK315387 A DK 315387A DK 315387 A DK315387 A DK 315387A DK 315387 D0 DK315387 D0 DK 315387D0
Authority
DK
Denmark
Prior art keywords
androst
diones
procedures
producing
Prior art date
Application number
DK315387A
Other languages
English (en)
Other versions
DK315387A (da
Inventor
Franco Buzzetti
Enrico Di Salle
Paolo Lombardi
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of DK315387D0 publication Critical patent/DK315387D0/da
Publication of DK315387A publication Critical patent/DK315387A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/005—3 membered carbocyclic rings in position 12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK315387A 1986-06-20 1987-06-19 Androst-4-en-3,17-dioner og fremgangsmaade til fremstilling deraf DK315387A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868615092A GB8615092D0 (en) 1986-06-20 1986-06-20 Androst-4-ene-317-diones

Publications (2)

Publication Number Publication Date
DK315387D0 true DK315387D0 (da) 1987-06-19
DK315387A DK315387A (da) 1987-12-21

Family

ID=10599809

Family Applications (1)

Application Number Title Priority Date Filing Date
DK315387A DK315387A (da) 1986-06-20 1987-06-19 Androst-4-en-3,17-dioner og fremgangsmaade til fremstilling deraf

Country Status (14)

Country Link
US (1) US4840943A (da)
EP (1) EP0250262A1 (da)
JP (1) JPS635096A (da)
KR (1) KR880000461A (da)
AU (1) AU592878B2 (da)
DK (1) DK315387A (da)
FI (1) FI872659A (da)
GB (1) GB8615092D0 (da)
HU (1) HU196431B (da)
IL (1) IL82894A0 (da)
NZ (1) NZ220744A (da)
PT (1) PT85121A (da)
SU (1) SU1537141A3 (da)
ZA (1) ZA874402B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
FI941359A0 (fi) * 1993-12-03 1994-03-24 Snow Brand Milk Products Co Ltd Foerfarande foer undersoekning av hormonoberoende tumoerer
DE4435368A1 (de) * 1994-09-22 1996-03-28 Schering Ag Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US10174070B2 (en) * 2005-09-30 2019-01-08 Endece Llc 6-substituted estradiol derivatives and methods of use
US8168621B2 (en) * 2005-09-30 2012-05-01 Endece, Llc 6-substituted estradiol derivatives and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB929985A (da) *
US2744120A (en) * 1953-01-14 1956-05-01 Olin Mathieson 1-dehydrotestololactone
GB1042291A (en) * 1961-11-08 1966-09-14 Organon Labor Ltd í¸-6ª‡-amino steroids and the preparation thereof
DE1250436B (da) * 1964-03-26
DK120154B (da) * 1968-02-29 1971-04-19 Schering Ag Fremgangsmåde til fremstilling af N-substituerede 4-amino-3-oxosteroid-4,6-diener af androstan- eller pregnanrækken eller deres ammoniumsalte.
US4235893A (en) * 1978-05-08 1980-11-25 Brodie Angela M Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis
DE3422187A1 (de) * 1984-06-12 1985-12-12 Schering AG, 1000 Berlin und 4709 Bergkamen 1,2ss-methylen-4-androsten- und 4,6-androstadien-3,17-dione
GB8519398D0 (en) * 1985-08-01 1985-09-04 Erba Farmitalia Steroidic aromatase inhibitors
GB8615093D0 (en) * 1986-06-20 1986-07-23 Erba Farmitalia Methylene derivatives of androst-4-ene-1317-diones

Also Published As

Publication number Publication date
FI872659A (fi) 1987-12-21
AU7429087A (en) 1987-12-24
US4840943A (en) 1989-06-20
PT85121A (en) 1987-07-01
ZA874402B (en) 1987-12-21
JPS635096A (ja) 1988-01-11
HU196431B (en) 1988-11-28
IL82894A0 (en) 1987-12-20
HUT44036A (en) 1988-01-28
NZ220744A (en) 1989-07-27
AU592878B2 (en) 1990-01-25
GB8615092D0 (en) 1986-07-23
EP0250262A1 (en) 1987-12-23
DK315387A (da) 1987-12-21
KR880000461A (ko) 1988-03-26
SU1537141A3 (ru) 1990-01-15
FI872659A0 (fi) 1987-06-16

Similar Documents

Publication Publication Date Title
NO872729D0 (no) Cefalosporinhydrat og fremgangsmaate for dets fremstilling.
DK166087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK522487A (da) Imidazopyridinforbindelse og fremgangsmaade til fremstilling deraf
DK664887D0 (da) 3-substituerede 3-aroyloxy-propanaminer og fremgangsmaade til fremstilling deraf
DK324386A (da) Substitueret androsta-1,4-dien-3,17-dion og fremgangsmaade til fremstilling deraf
DK550386A (da) Engangsble og fremgangsmaade til fremstilling deraf.
DK3687A (da) Polypeptider og fremgangsmaade til fremstilling deraf
DK491087A (da) Tumor-egress-faktor (egressin) og fremgangsmaade til fremstilling heraf
DK290287A (da) Antibiotika og fremgangsmaade til fremstilling deraf
NO855026L (no) Aminoacyllabdaner og fremgangsmaate til fremstilling derav.
DK315387D0 (da) Androst-4-en-3,17-dioner og fremgangsmaade til fremstilling deraf
DK269987D0 (da) Enzym og fremgangsmaade til fremstilling deraf
NO864194L (no) Slipekorn og fremgangsmaate til fremstilling derav.
DK203087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK477287A (da) Pyrido-benzoxadiazin-derivater og fremgangsmaade til fremstilling deraf
DK397788D0 (da) Polyarylalkan-oligomer-praeparater og fremgangsmaade til fremstilling deraf
NO870210L (no) Fremgangsmaate og anordning for avskinning.
NO873197D0 (no) Bedoevelsespreparat og fremgangsmaate for anvendelse av dette.
DK103889D0 (da) Benzimidazooe1,2-caachinazoliner og fremgangsmaade til fremstilling heraf
DK362987D0 (da) Hexahydroarylquinolizin og fremgangsmaade til fremstilling deraf
DK34491D0 (da) Ekstruderet, biaksialt strakt skumplastroer og fremgangsmaade til fremstilling deraf
DK270087A (da) Enzym og fremgangsmaade til fremstilling deraf
DK585988A (da) Isopolypeptider og fremgangsmaade til fremstilling deraf
DK265288D0 (da) Oximino-ether-forbindelser og fremgangsmaade til fremstilling deraf
DK160087A (da) Katalysatorkomponent og fremgangsmaade til fremstilling deraf